z-logo
open-access-imgOpen Access
Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza--author's response
Author(s) -
Hong Zhang
Publication year - 2008
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkn220
Subject(s) - pandemic , virology , sialidase , drug , influenza pandemic , covid-19 , pandemic influenza , microbiology and biotechnology , medicine , biology , virus , neuraminidase , pharmacology , infectious disease (medical specialty) , outbreak , disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom